...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >Comparison of Serum 25-Hydroxyvitamin D Levels in Patients With Malignant and Benign Gynaecological Disease
【24h】

Comparison of Serum 25-Hydroxyvitamin D Levels in Patients With Malignant and Benign Gynaecological Disease

机译：血清25-羟基苯胺D水平对恶性和良性妇科疾病患者的比较

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background/Aim: Many studies have shown an antiproliferative, anti-inflammatory, anti-angiogenetic, and apoptosis-inducing effect of Vitamin D. A vitamin D deficiency has been associated with an increased risk for different types of cancer. This study examined vitamin D 25(OH)D levels in gynaecological cancers in comparison with benign gynaecological diseases. Patients and Methods: Serum 25(OH)D levels in 688 gynaecological patients (488 with malignant, 200 with a benign gynaecological disease) were assayed between 2009 and 2015 using an electrochemiluminescence immunoassay. Results: In total, the 25(OH) D levels in cancer patients were lower, but not significantly lower than those in cancer-free patients. Significant results were shown regarding seasonal effects for patients with breast-, endometrial and ovarian cancer. No significant effects occurred with regard to menopause status, nicotine, or grade in relation to 25(OH)D levels. Conclusion: 25(OH)D levels seem to influence gynaecological cancers.
机译：背景/目的：许多研究表明了维生素D的抗增殖，抗炎，抗血管生成和凋亡诱导效应。维生素D缺乏症与不同类型癌症的风险增加有关。该研究与良同妇科疾病相比，检查了妇科癌症中的维生素D 25（OH）D水平。患者和方法：使用电化学发光免疫测定，在2009和2015之间测定688例妇科患者（488患者的血清患者（488，良性妇科疾病）中的血清25（OH）D水平。结果：癌症患者的25（OH）D水平较低，但不显着低于无抗癌患者的患者。关于乳腺癌，子宫内膜和卵巢癌患者的季节性效果显示了显着的结果。关于更年期状态，尼古丁或相对于25（OH）D水平的级别没有显着影响。结论：25（OH）D水平似乎影响妇科癌症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号